Prelude Therapeutics, Inc.

{
  "main_header": {
    "sid": 1246322,
    "name": "Prelude Therapeutics, Inc.",
    "stock_name": "Prelude Therapeutics, Inc.",
    "full_name": "Prelude Therapeutics, Inc.",
    "name_url": "stocks-analysis/prelude-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "2.02",
    "chg": -0.27,
    "chgp": "-11.79%",
    "dir": -1,
    "prev_price": "2.29",
    "mcapval": "79.65",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US74065P1012",
    "curr_date": "Feb 05",
    "curr_time": "",
    "bse_nse_vol": "711.45 k",
    "exc_status": "Active",
    "traded_date": "Feb 05, 2026",
    "traded_date_str": "2026 02 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/prelude-therapeutics-inc-1246322-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Prelude Therapeutics Experiences Revision in Its Stock Evaluation Amid Mixed Financial Trends",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/prelude-therapeutics-inc-financial-trend-shifts-from-positive-to-flat-amid-increased-losses-3715755",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/PreludeTherapeu_fintrenddot_3715755.png",
        "date": "2025-11-19 15:43:57",
        "description": "Prelude Therapeutics, Inc. has reported a mixed financial performance for the quarter ending June 2025, with increased net profit and sales but significant challenges in operating cash flow and return on capital employed. Despite these hurdles, the company has outperformed the S&P 500 over the past year."
      }
    ],
    "total": 9,
    "sid": "1246322",
    "stock_news_url": "https://www.marketsmojo.com/news/prelude-therapeutics-inc-1246322"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Prelude Therapeutics Experiences Revision in Its Stock Evaluation Amid Mixed Financial Trends

2025-11-19 15:43:57

Prelude Therapeutics, Inc. has reported a mixed financial performance for the quarter ending June 2025, with increased net profit and sales but significant challenges in operating cash flow and return on capital employed. Despite these hurdles, the company has outperformed the S&P 500 over the past year.

Read full news article

View All News